Song Paul Y., CEO of NKGen Biotech ($NKGN), made one open market purchase of company shares in the last year, totaling $2.65 million. His most recent buy occurred on May 5, 2025. This ranks him 256th among nearly 5,000 insiders by purchase value, above the average of $1.46 million across 3.29 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | NKGen Biotech, Inc. | $NKGN | Song Paul Y. | Chief Executive Officer | P | Common Stock | 20849725 | $0.13 | 21,020,846.0000 | 44,947,588 | 9999.99% | 46.39% |
| May 5, 2025 | NKGen Biotech, Inc. | $NKGN | Song Paul Y. | Chief Executive Officer | P | Warrant | 41699449 | $0.13 | 41,699,449.0000 | 44,947,588 | 9999.99% | 92.77% |
| Dec. 6, 2024 | NKGen Biotech, Inc. | $NKGN | Song Paul Y. | Chief Executive Officer | A | Stock Option (right to buy) | 2000000 | $0.00 | 2,000,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | NKGen Biotech, Inc. | $NKGN | Song Paul Y. | Chief Executive Officer | A | Stock Option (right to buy) | 1260000 | $0.00 | 1,260,000.0000 | 0 | 9999.99% | 0.00% |